Get started
Author

E. Mgar

Observed name: Ekaterina A. Mgar'
Observed institution: City Clinical Oncology Center
ORCID: 0009-0003-6646-9442
Observed ORCID: 0009-0003-6646-9442
OpenAlex ID: A5121029250
97P Comparison of the efficacy of regorafenib, reintroduction and rechallenge of chemotherapy (CT) with anti-EGFR in the third-line treatment of metastatic colorectal cancer (mCRC) with wild-type RAS and BRAF of left-sided localization: Results of a multicenter retrospective study
2026 · E. Kuzmina, M.Y. Fedyanin, et al. · Annals of Oncology
PDF
Comparison of the efficacy of regorafenib and reintroduction of a combination of chemotherapy with anti-EGFR antibody in the third-line treatment of metastatic colorectal cancer with wild-type RAS and BRAF genes of left-sided localization – Results of a multicenter study of real-world practice
2026 · Evgeniya S. Kuzmina, Mikhail I. Fedyanin, et al. · Journal of Modern Oncology
PDF
238eP Comparison of the efficacy of regorafenib and reintroduction of chemotherapy (CT) with anti-EGFR in the 3rd-line treatment of metastatic colorectal cancer (mCRC) with wild-type RAS and BRAF of left-sided localization - results of a retrospective study
2025 · E. Kuzmina, P. Feoktistova, et al. · Annals of Oncology
Works count: 3
Citation count:
H-index:
I10-index:
Year
Topic
Type